Our chick Pfizer (PFE) delivered exactly what Buffy expected!
📈 Adjusted EPS grew 12% YoY to $0.92 per share in Q1.
📊 The company reaffirmed its 2025 EPS guidance at $2.90, which gives us an incredibly low forward P/E of just 8.3x! 💰
And guess what? The market loves it—PFE shares are up over 4% 🤑 🚀
#portfolio